Researchers at Cold Spring Harbor Laboratory (CSHL) have unveiled a groundbreaking anti-aging therapy using chimeric antigen receptor (CAR) T cells to target senescent cells associated with age-related diseases. Led by assistant professor Corina Amor Vegas, MD, PhD, the team tested this senolytic CAR T cell therapy in aging mice, revealing significant improvements in metabolic function and exercise capacity.
The study, published in Nature Aging, provides proof-of-principle evidence that senolytic cell therapies can mitigate symptoms associated with physiological aging.
Continue reading… “Revolutionizing Aging: CAR T Cell Therapy Shows Promise in Rejuvenating Healthspan”
